Blog
Important Clinical Trial Facts
Cameron from Total Biopharma introduces an interesting artical about how clinical trials are being designed and executed to fit the changing needs of the industry. With costs and complexity increasing in clinical reseach, Total Biopharma offers their own A-Z...
Drug Developers Pushing Through Adversity
Centerwatch.com produced an interesting article on the implementation of new strategies to improve drug developer’s access to comparator drugs for clinical testing. The article brings to light the difficulty of obtaining comparator drugs, with the Tufts Center for...
Costs of Drug Development Revisited
Yevgeniy Feyman of Forbes has written an intriguing article entitled “Shocking Secrets of FDA Clinical Trials Revealed” the costs of bringing a new drug to market. Feyman shares that “according to Joseph Dimasi of the Tufts Center for the Study of Drug Development,...
Join us on February 21st at the Kelley School Life Sciences Event
With China’s economy continuing to develop many people in their population will begin to receive advanced healthcare for the first time. Now it’s time to look to see how China can learn from the healthcare insurance systems from around the world and what opportunities...
Save the Date: Gretchen Bowker, Pearl COO to Speak at MAGI’s Clinical Research Conference, Boston, May 4-7
This year’s MAGI Clinical Research Conference will take place May 4-7 in Boston, Massachusetts. Pearl’s Gretchen Bowker will serve on a panel discussing “Regulatory Myths: ‘common’ wisdom about what the rules don’t actually say” during the Regulatory Compliance...